Investors' focus will likely be on GILD's HIV franchise performance and oncology sales when the company reports ...

Today's Research Daily features new research reports on 16 major stocks, including Uber Technologies, Inc. (UBER), Comcast ...

This was the stock's second consecutive day of losses.

A daily rundown of the economic reports and corporate earnings that will be grabbing the market’s attention in the week ahead ...

RBC Capital analyst Brian Abrahams maintained a Hold rating on Neurocrine (NBIX – Research Report) yesterday and set a price target of $148.00.

CPI Readings Due in U.S. Next Week Monday U.S. Featured Earnings McDonalds (NYSE:MCD) (Q4) EPS of $2.82 compared to $2.95 in ...

Researchers discovered the importance of an enzyme that promotes growth of certain lung cancers. Lung cancer is a ...

Remarkable progress in HIV science has brought us a groundbreaking long-acting injectable drug offering six months of ...

The AJ Bell team analyses the week ahead for stocks including the release of BP and British American Tobacco full-year ...

Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Read more about the events that may impact stock prices next week. Monday - February 10 ...